Evaluating Adherence of PrEP Therapies

evaluating adherence of prep therapies

Sumary of Evaluating Adherence of PrEP Therapies:

  • Investigators at Howard Brown Health in Chicago wanted to study real-world use patterns and HIV seroconversion for F/TAF and F/TDF.
  • Laura Rusie, ScM Director of Data, Evaluation, and Epidemiology, Howard Brown Health led the study and presented the oral abstract, Comparing Adherence to HIV PrEP Among New, Male PrEP Users Initiating F/TAF vs.
  • F/TDF, at the 11th International AIDS Society Conference on HIV Science.
  • “Because of the fairly recent approval of F/TAF, there is a need for real-world contemporaneous data comparing outcomes among users using these two different regimens,” Rusie said in her presentation.
  • “This work aims to be among the first to use real-world claims data to analyze two outcomes: adherence and HIV seroconversions for each regimen.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close